Status:
COMPLETED
Use of an Internet-Based Insomnia Intervention to Prevent Cognitive Decline in Adults With Mild Cognitive Impairment
Lead Sponsor:
University of Virginia
Conditions:
Mild Cognitive Impairment
Cognitive Impairment
Eligibility:
All Genders
55+ years
Phase:
NA
Brief Summary
The purpose of the study is to determine feasibility of an online program providing cognitive behavioral therapy for insomnia in adults with cognitive impairment. The study involves the use an Intern...
Detailed Description
Mild cognitive impairment in older adults. Mild Cognitive Impairment (MCI) is recognized as an early stage cognitive disorder, a condition where patients live independently and are able to still perfo...
Eligibility Criteria
Inclusion
- 55 years of age or older
- ability to read and speak English
- US resident
- MCI diagnosis or scores within acceptable range on R-BANS assessment.
- regular access to Internet and Email
- willingness to use Internet and Email
- ability to use a computer
- no more than 6.5 hours of sleep per night
- the sleep disturbance (or associated daytime fatigue) must cause significant distress or impairment in social, occupational, or other areas of functioning over past 3 months
- sleep onset latency \> 30 minutes at least 3x/week for past three months; OR wake after sleep onset \>30 minutes at least 3x/week for past three months
- Participants on stable (defined as no change in the past 3 months) medication regimens will be eligible including sleep medications, unless the medication is known to cause insomnia (e.g., steroids).
Exclusion
- bedtime outside of 8pm-2am and arise times outside of 4-10am
- current psychological treatment for insomnia
- initiation of psychological or psychiatric treatment within past 3 months
- current severe/very severe depression from QIDS-C16
- current moderate/high risk suicide or substance use disorder in 12 months from MINI
- other untreated sleep disorders (e.g., obstructive sleep apnea, restless legs syndrome)
- current diagnosis of Huntington's or Parkinson's disease
- current treatment for hyperthyroidism
- currently undergoing chemotherapy
- presence of asthma or respiratory concerns with night treatment
- chronic pain treated with opioids
- epilepsy
- inability to provide informed consent
- Not concurrently enrolled in any other intervention or educational study targeting sleep.
Key Trial Info
Start Date :
December 5 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 28 2020
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT04382365
Start Date
December 5 2018
End Date
May 28 2020
Last Update
April 27 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Of Virginia
Charlottesville, Virginia, United States, 22908